CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Korea Pharma Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Korea Pharma Co Ltd
87, Jeyakgongdan 3-gil, Hyangnam-eup
Phone: +82 313537291p:+82 313537291 HWASEONG, 18622  South Korea Ticker: 032300032300

Business Summary
Korea Pharma Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medicinal products. The Company's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Eun HuiPark 55
Vice President Byeong JinLee 64
Vice President Jin WuLee 65
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 289 (As of 12/31/2023)
Outstanding Shares: 10,906,701 (As of 12/31/2023)
Shareholders: 25,454
Stock Exchange: KDQ
Fax Number: +82 313537294


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024